A detailed history of Logos Global Management LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Logos Global Management LP holds 300,000 shares of IONS stock, worth $11.9 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares
300,000
Previous 300,000 -0.0%
Holding current value
$11.9 Million
Previous $14.3 Million -0.0%
% of portfolio
1.34%
Previous 1.34%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $10.9 Million - $14.3 Million
300,000 New
300,000 $14.3 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.